Richard Otto is a multi-faceted life science executive with decades of experience in big pharma and CEO experience of public medical device companies. Throughout his career, Richard has raised over $100MM of capital and founded a senior management consulting firm focused on the life sciences.
Richard has experience in managing all aspects of a corporation to create value for all stakeholders; reversing negative sales trends, budget efficiency, shareholder communications, license and patents, product development and regulatory compliance.
As a specialist in cardiovascular, gene therapy, cryotherapy, health IT and turnarounds, he brings a proven track record of commercialization to the IGNITE Network and the IGNITE Advisory Group.
Current role